Skip to main content

On the Biocompatibility of Fe3O4 Ferromagnetic Nanoparticles with Human Blood Cells

Buy Article:

$113.00 plus tax (Refund Policy)


Magnetic particles are currently applied to special biomedical and environmental applications owing to their unique magnetic, morphological and substance-carrying capabilities. Very recently we introduced Magnetically Assisted Hemodialysis (MAHD), an innovative therapeutic application of Ferromagnetic Nanoparticles (FNs) for the treatment of End-Stage Renal Disease (ESRD). MAHD can be employed for the selective and efficient removal of toxins that, although of high biological importance, they cannot be handled by current Hemodialysis strategies. This work is focused on evaluating the biocompatibility of Fe3O4 FNs with cells of donated human blood, namely Red Blood Cells (RBCs), White Blood Cells (WBCs) and Platelets (Plts). To that end, optical microscopy and atomic force microscopy were employed for the morphological examination of blood cells that were maturated under the presence of Fe3O4 FNs by means of mild incubation up to 120 min at T = 20 °C. As a conclusion we have not detected noticeable interference between RBCs, WBCs and Plts with FNs for the maturation conditions and the extreme FNs concentrations examined in this work.


Document Type: Research Article


Publication date: 2010-09-01

More about this publication?
  • Journal for Nanoscience and Nanotechnology (JNN) is an international and multidisciplinary peer-reviewed journal with a wide-ranging coverage, consolidating research activities in all areas of nanoscience and nanotechnology into a single and unique reference source. JNN is the first cross-disciplinary journal to publish original full research articles, rapid communications of important new scientific and technological findings, timely state-of-the-art reviews with author's photo and short biography, and current research news encompassing the fundamental and applied research in all disciplines of science, engineering and medicine.
  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • Terms & Conditions
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free ContentFree content
  • Partial Free ContentPartial Free content
  • New ContentNew content
  • Open Access ContentOpen access content
  • Partial Open Access ContentPartial Open access content
  • Subscribed ContentSubscribed content
  • Partial Subscribed ContentPartial Subscribed content
  • Free Trial ContentFree trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more